medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2021, Number 4

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2021; 37 (4)

Characterization of the complete blood count of Cuban older adults treated with Biomodulina T®

Simón PAM, Hernández RY, Hernández RE, Marsán SV, Triana MY, Reyes ZMC, Macías AC

Language: Spanish
References: 13
Page: 1-10
PDF size: 309.84 Kb.


ABSTRACT

Introduction: In the last decade it has been evident the rise in the older adults in Cuba. The process of aging causes changes in the immune system that affects the development and function.
Objective: To characterize hematological and immunological parameters by means of the complete blood count in Cuban older adults before and after the administration of Biomodulin T®.
Materials and methods: A descriptive and observational study was to conducted to evaluate the use of Biomodulina T, the statistic package used was the GraphPad Prism (version 6.00). The data that showed a normal distribution were processed using the Student´s t test. The Wilcoxon´s signed range test with was used when the data did not comply with the normal distribution. Both for a signification level of p < 0.05.
Results: Women predominated in relation to men, representing 27.6%. There was a predominance of older adults aged 76-80 years. The global leukocyte count remained within normal parameters and platelets decreased only in 5 patients after the administration of Biomodulina T, that results were not statistically significant.
Conclusion: It was shown that the Biomodulina T did not modify the hemogram results in the elderly patients.


REFERENCES

  1. Ramos-Monteagudo AM, Jordi-García MJ. Envejecimiento demográfico en Cuba y los desafíos que presenta para el Estado. Medwave 2018. Jul-Ago; 18(4):7231 DOI: https://10.5867/medwave.2018.04.7231

  2. Jairo A, Cerón C. Inmunosenescencia. En: Jorge Hernán López Ramírez, Carlos Alberto Cano Gutiérrez, José Fernando Gómez Montes, editores. Fundamentos de Medicina, Geriatría. Medellín: Corporación para investigaciones biológicas; 2006.p. 487-89.

  3. Burns EA, Goodwin JS. Immunology of Aging. In: Christine K. Cassel, Rosanne MLeipzig, editors. Geriatric Medicine An Evidence-Based Approach. New York: Springer; 2006. p 783-800.

  4. Megía González R. El Blog de Genotipia. ¿Cómo funcionan los linfocitos? Inmunidad y diversidad genética [Internet]. Valencia: Medigene Press (Genotipia). Publicado 11/04/2018. [acceso 23/11/2019]. Disponible en: Disponible en: https://genotipia.com/linfocitos/

  5. Sebastián N. La linfopenia podría servir como biomarcador en pacientes de Covid-19. Gaceta Médica [Internet]. España. Publicado 26/03/2020 [acceso 27/04/2020]. Disponible en: https://gacetamedica.com/investigacion/la-linfopenia-podria-servir-como-biomarcador-en-pacientes-de-covid-19/

  6. Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained immunity: A program of innate immune memory in health and disease. Science. 2016 Apr;352(6284):aaf1098. DOI: https://10.1126/science.aaf1098

  7. Salvador J, Adams EJ, Ershler R, Ershler WB. Future challenges in analysis and treatment of human immune senescence. Immunol Allergy Clin North Am. 2003 Feb;23(1):133-48. DOI: https://10.1016/s0889-8561(02)00076-0

  8. Ríos M, Fommell I, Cruz M. Algunos aspectos de la inmunofarmacología de la Biomodulina T. Congreso de la Sociedad Cubana de Ciencias Farmacéuticas, 5. La Habana: 17 de abril de 1993.

  9. Alfonso HA. Estudio toxicológico de Biomodulina T. Centro Nacional de Sanidad Agropecuaria. Informe de Ensayos Preclínicos presentado al CECMED, La Habana: 1993.

  10. Word Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). 30 January 2020 [acceso 28/01/2020]. Disponible en: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

  11. Friedman N, Alter H, Hindiyeh M, Mendelson E, Shemer Avni Y, Mandelboim M. Human Coronavirus Infections in Israel: Epidemiology, Clinical Symptoms and Summer Seasonality of HCoV-HKU1. Viruses. 2018 Sep 21;10(10):515. DOI: https://10.3390/v10100515

  12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-13. DOI: https://10.1016/S0140-6736(20)30211-7

  13. Word Health Organization. Global Surveillance for human infection with novel coronavirus (2019-nCoV). Interim guidance. 31 January 2020 [acceso 28/02/2020]. WHO-2019-nCoV-SurveillanceGuidance-2020.8. Disponible en: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov)




2020     |     www.medigraphic.com